BANP

Across TCGA pan-cancer cohorts, BANP mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated BANP data layer compared with 29 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher BANP mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated BANP expression acts as an unfavorable survival marker, although some lineages such as LSCC and GBM show a favorable association.

CCRCC, LSCC, and PDAC are the cancer types where BANP mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Quartile	II,III,IV	0.522	0.880	.024	15	view →
LSCC	OS	Median	All	0.903	0.724	.006	15	view →
PDAC	OS	Median	III,IV	0.360	0.829	.008	12	view →
GBM	DFS	Tertile	All	0.515	0.268	.022	11	view →
UCEC	DFS	Tertile	III,IV	0.529	1.000	.049	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

BANP–CCRCC (OS)

Open the CCRCC breakdown →